Terns Pharmaceuticals Competitors and Similar CompaniesClear all
Terns Pharmaceuticals's competitors and similar companies include Rigel Pharmaceuticals.
 Terns Pharmaceuticals Terns Pharmaceuticals is a biopharmaceutical company developing small-molecule single-agent and combination therapy for the treatment of non-alcoholic steatohepatitis and other chronic liver diseases. |  Rigel Pharmaceuticals Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases. | |
Founding Date | Founding Date 2017 | Founding Date 1996 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Foster City, US HQ | Locations South San Francisco, US HQ |
Employees | Employees 59 | Employees 1633% increase |
Valuation ($) | Valuation ($) 580.9 m | Valuation ($) 256 m |
Financial | ||
Net income | Net income ($96.2m) (FY, 2025) | Net income $367m (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 30m | Total funding raised $ 130m |
For sources of this data, please see the company profile
View Company Profiles
Rigel Pharmaceuticals
HQ
South San Francisco, US
Employees
163↑ 3% increase
Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases.
View company